Circadian, Exercise, Testosterone
Conditions
Keywords
saliva, blood, urine
Brief summary
It is generally accepted that chemical testing of biologic fluids is the most objective means of diagnosis of drug use. In recent years saliva has attracted much attention. The prime advantage of saliva is that it offers non-invasive, stress-free and real-time repeated sampling whereas blood collection is undesirable, difficult and expensive. In addition, it is known that androgens such as testosterone can be assayed in saliva, as these steroids pass the endothelial-epithelial barriers by passive diffusion. Nevertheless, the correlations of blood, urine and saliva concentrations are not well documented. In recent reviews, it is pointed out that salivary hormone analysis could be a promising method for sports medicine and doping control, but much work is needed before the use of saliva samples in this area receives the acceptance. According to recent studies the increase of testosterone concentration in saliva is significantly higher than alterations of steroid concentrations (or ratios) in blood or urine. Saliva concentration may therefore serve as screening parameter to select suspicious cases for further target evaluation (e.g. by IRMS). This may be beneficial to identify cases of transdermal administration of low steroid doses. It is therefore the aim of the present project to detect administered testosterone in saliva and compare these levels to those in blood and urine. The intention is not to detect high dosage but low dosage abuse of testosterone, as a single-dose by patch application. From the practical point of view saliva could offer a complementary specimen for a pre-screening of testosterone. So it could be assumed that salivary testosterone exceed upon plasma and/or urine levels. So the present study could be the base for a new method to preselect the suspicious samples for testosterone abuse.
Interventions
Low-dose testosterone supplementation will be facilitated by using hormone patches. For pharmacokinetic aspects circadian profiles of saliva/blood/urine will be measured under native conditions and under exogene hormone application. In addition, cross-reactivity of a standardized exercise bout and hormone application will be of further interest.
Sponsors
Study design
Eligibility
Inclusion criteria
* male * healthy * informed consent
Exclusion criteria
* any metabolic, cardiovascular, pulmonary disorder * neoplastic or hormonal disorders * active sports competitor * disorders which hinder cycling ergometry
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Salivary testosterone concentration | 2 weeks | Salivary testosterone concentration will be quantified in relation to circadian time, exercise, and external low-dose hormone application. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Serum testosterone | 2 weeks | Serum testosterone concentration (free/bound) will be quantified in relation to circadian time, exercise, and external low-dose hormone application. |
| Circulating microRNA in blood plasma | 2 weeks | Circulating microRNA in blood plasma will be screened in relation to circadian time, exercise, and external low-dose hormone application. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Testosterone in hairs | 4 weeks | At onset, 2 weeks and 4 weeks after testosterone application steroid hormone concentration will be quantified in scalp hair. |
Countries
Germany